RankAlpha logo
Back to Rankings

CNSY

CerenomeF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
CNSY vs peer average
26/100
CNSY vs. peer average (F vs. C)
Grade spread
A 2 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

BRNS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $24.24M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerBRNSBarinthus Biotherapeutics
CNSY
Cerenome
BRNS
Barinthus Biotherapeutics
Grade
F
D
Momentum
0
9
Value
41
58
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs BRNS

CNSY / BRNS
Grade Position
Below peers
CNSY vs. peer average (F vs. C)
26/100
Momentum
0
BRNS
Value
41
BRNS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CNSY
1
BRNS
Barinthus Biotherapeutics plc ADR
D
40/100
-1
2
CLRB
Cellectar Biosciences Inc Common
A
100/100
-4
3
QNTM
Quantum Biopharma Ltd Subordinate Voting Shares Class B Common
C
60/100
-2
4
ACTU
Actuate Therapeutics Inc Common
F
20/100
Even
5
TVRD
Tvardi Therapeutics Inc Common
F
20/100
Even
BRNS is the first peer returned for this comparison set.